Log In
Print this Print this

BAX 817

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant Factor VIIa (rFVIIa)
Molecular Target Factor VIIa
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A or B; Treat hemophilia in pediatric patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today